• Front Matter R1-R14

• Executive Summary 1-16

• 1 Introduction and Background 17-28

• 2 Defining Safety for Infants 29-40

• 3 Comparing Infant Formulas with Human Milk 41-54

• 4 Strengthening the Current Processes to Evaluate New Ingredients for Infant Formulas 55-69

• 5 Testing Ingredients with Preclinical Studies 70-97

• 6 Going Beyond Current Clinical Studies 98-159

• 7 Selecting an In-Market Surveillance Plan 160-174

• A Acronyms and Glossary 175-178

• B Composition of Infant Formulas and Human Milk for Feeding Term Infants in the United States 179-182

• C Redbook Table of Contents 183-185

• D Applying the Recommended Approaches 186-203

• E Biographical Sketches of Committee Members 204-206

" Front Matter ." Infant Formula: Evaluating the Safety of New Ingredients . Washington, DC: The National Academies Press, 2004 .

Please select a format: